300529.SZ
健帆生物
SZSE · Healthcare · C 制造业 · CN
CNY 15.56
−1.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 19.09x
- P/E 2027E
- 17.48x
- P/E 2028E
- 15.64x
- P/S forward
- 25.75x
Trailing multiples
Trailing twelve months
- P/E TTM
- 23.32x
- PEG TTM
- —
- Price / book
- 3.72x
- Price / sales
- 6.14x
- Price / cash flow
- 17.55x
Enterprise value
- Enterprise value
- CNY 12.1B
- EV / sales
- 5.99x
- EV / EBITDA
- 14.71x
- EV / EBIT
- 16.95x
- Market cap
- CNY 12.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026